A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2011
11/17/2011	WO2011142478A1 Canagliflozin containing tablets
11/17/2011	WO2011141935A2 Soft capsular preparation of artemether and lumefantrine and process to manufacture same
11/17/2011	WO2011141929A2 Aqueous pharmaceutical compositions of fluticasone and olopatadine
11/17/2011	WO2011141904A1 Viscous carbohydrate compositions and methods for the production thereof
11/17/2011	WO2011141819A1 Improved methods for preparing squalene
11/17/2011	WO2011141783A2 Pharmaceutical composition comprising irbesartan
11/17/2011	WO2011141750A1 Coated nutraceutical and pharmaceutical compositions
11/17/2011	WO2011141721A2 Compositions
11/17/2011	WO2011141708A2 New particles of tetracyclines and protecting agent
11/17/2011	WO2011141685A2 Systemic nasal compositions comprising cocoyl proline or at least one of the constituents thereof
11/17/2011	WO2011141611A1 Oleuropein compositions for healing wounds and ulcers in elderly people and/or diabetics
11/17/2011	WO2011141490A1 Combination of active loaded granules with additional actives
11/17/2011	WO2011141489A1 Manufacturing of active-free granules and tablets comprising the same
11/17/2011	WO2011141488A2 Pharmaceutical compositions comprising hydromorphone and naloxone
11/17/2011	WO2011141483A2 Stable pharmaceutical formulations containing an antihistaminic
11/17/2011	WO2011141241A1 Alcohol-resistant oral pharmaceutical form
11/17/2011	WO2011141192A1 Pharmaceutical dosage form comprising one or more antiretroviral active ingredients
11/17/2011	WO2011141108A2 New dosage form for cineole
11/17/2011	WO2011140981A1 Use of 5'-methoxy-3',4'-methylenedioxycinnamic acid isobutylamide on preparing medicaments for anti-depression
11/17/2011	WO2011140872A1 Slow release tablet of elemene anti-tumor plant medicine
11/17/2011	WO2011140856A1 Snow lotus extract, preparing method and application thereof
11/17/2011	WO2011140676A1 Rhizoma gastrodiae plant extract used to prevent and treat alzheimer disease and vascular dementia and mixed type diseases thereof and preparative method thereof
11/17/2011	WO2011140627A1 Nucleic acid-containing lipid particles and related methods
11/17/2011	WO2011113855A3 Pharmaceutical composition for treatment of increased intraocular pressure
11/17/2011	WO2011113616A9 A nanoparticle comprising a micelle formed by an amphiphilic block- copolymer and encapsulating a gadolinium complex
11/17/2011	WO2011113507A3 Use of nitrocarboxylic acids for the treatment, diagnosis and prophylaxis of aggressive healing patterns
11/17/2011	WO2011094221A3 Moire patterns generated by angular illumination of surfaces
11/17/2011	WO2011091000A3 Oral care compositions and methods
11/17/2011	WO2011090932A3 A method of treating sinusitis, including chronic sinusitis
11/17/2011	WO2011090725A3 Gastroretentive solid oral dosage forms with swellable hydrophilic polymer
11/17/2011	WO2011090724A3 Gastroretentive solid oral dosage forms with lipid-based low-density excipient
11/17/2011	WO2011087689A3 Emulsion-based process for preparing microparticles and workhead assembly for use with same
11/17/2011	WO2011087629A3 Microcrystalline cellulose and calcium carbonate compositions useful as recompactible pharmaceutical excipients
11/17/2011	WO2011085209A3 Methods and compositions for applying moxifloxacin to the ear
11/17/2011	WO2011085162A3 Topical transdermal dexmedetomidine compositions and methods of use thereof
11/17/2011	WO2011084620A3 Particles for multiple agent delivery
11/17/2011	WO2011084518A3 Therapeutic polymeric nanoparticles comprising corticosteroids and methods of making and using same
11/17/2011	WO2011083402A3 Immediate release compositions of acid labile drugs
11/17/2011	WO2011082369A3 Injectable formulations for parenteral administration
11/17/2011	WO2011079302A3 Swallowable drug delivery device and methods of drug delivery
11/17/2011	WO2011079260A3 Stabilized virus like particles having enhanced mucosal immunogenicity
11/17/2011	WO2011076807A3 Lipids, lipid compositions, and methods of using them
11/17/2011	WO2011072069A3 Gastric retentive pharmaceutical compositions for extended release of polypeptides
11/17/2011	WO2011071970A3 Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt)
11/17/2011	WO2011071904A3 Inhibiting bacterial infection and biofilm formation
11/17/2011	WO2011068774A3 Methods for regulating gelation of hydrogel solutions and uses thereof
11/17/2011	WO2011061252A3 Combination of alpha- 2 adrenergic receptor agonist and non-steroidal anti - inflammatory agent for treating or preventing an inflammatory skin disorder
11/17/2011	WO2011060099A3 Sunscreen compositions comprising uniform, rigid, spherical, nanoporous calcium phosphate particles, and methods of making and using the same
11/17/2011	WO2011056702A3 Fast dissolving/disintegrating coating compositions
11/17/2011	WO2011047689A3 Spla2 hydrolysable liposomes with improved storage stability
11/17/2011	WO2011038278A3 Micelle encapsulation of therapeutic agents
11/17/2011	WO2011014850A3 Topical eutectic-based formulations
11/17/2011	WO2011005478A3 Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
11/17/2011	WO2011002972A3 Stable shellac enteric coating formulation for nutraceutical and pharmaceutical dosage forms
11/17/2011	WO2010140007A3 Tamper resistant dosage form comprising a matrix and melt - extruded particulates comprising a drug
11/17/2011	WO2010130982A3 Microparticles comprising immunosuppressant
11/17/2011	WO2006116180A8 Hydrogel constructs using stereolithography
11/17/2011	US20110281914 Fentanyl composition for nasal administration
11/17/2011	US20110281732 Crosslinked Polyvinylpyrrolidone Compositions
11/17/2011	US20110281021 Rapidly disintegrating dosage form for releasing active ingredients in the oral cavity or in body cavities
11/17/2011	US20110280949 Microparticles for use in immunogenic compositions
11/17/2011	US20110280948 Compositions and methods for separating, characterizing and administering soluble selenoglycoproteins
11/17/2011	US20110280947 Embolization
11/17/2011	US20110280946 Surface-Treating Agents, Surface-Treated Powders, And Cosmetics Comprising The Same
11/17/2011	US20110280945 Novel method for the preparation of granulates of active constituents, and granulates as obtained
11/17/2011	US20110280944 Fibrous microcapsules and methods of assembly and use thereof
11/17/2011	US20110280942 Film coating composition and methods of making and using the same
11/17/2011	US20110280941 Compositions of proton pump inhibitors and insulin secretagogues, and methods of their use to treat diabetes
11/17/2011	US20110280940 Di-Vanilloyl And Tri-Vanilloyl Derivatives For Use In Anti-Cancer Therapy
11/17/2011	US20110280939 Oral particle including pseudoephedrine hydrochloride and cetirizine dihydrochloride
11/17/2011	US20110280938 Sustained release pharmaceutical composition of quetiapine and process for preparation thereof
11/17/2011	US20110280937 Hard capsule
11/17/2011	US20110280936 Self Breaking Tablets
11/17/2011	US20110280935 Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies
11/17/2011	US20110280934 Increased Expression of Specific Antigens
11/17/2011	US20110280933 Epicatechin compositions and methods
11/17/2011	US20110280932 Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (dmard) and an anti-cancer agent
11/17/2011	US20110280931 Matrix metalloproteinase inhibitor
11/17/2011	US20110280930 Products and methods for stimulating an immune response
11/17/2011	US20110280929 Sirna of nf-kb p105 for inhibiting cell proliferation and migration and a composition comprising same
11/17/2011	US20110280928 Wound Care Device Having Fluid Transfer Properties
11/17/2011	US20110280926 Wound dressing
11/17/2011	US20110280925 Dual And Single Layer Dosage Forms
11/17/2011	US20110280924 Biodegradable filler for restoration of alveolar bones
11/17/2011	US20110280923 Bolus devices for the delivery of active agents to animals
11/17/2011	US20110280921 Antibacterial hydrogel and use thereof in orthopedics
11/17/2011	US20110280919 Reinforced Absorbable Synthethic Matrix for Hemostatic Applications
11/17/2011	US20110280916 Stable hydroalcoholic oral spray formulations and methods
11/17/2011	US20110280915 Encapsulation of pancreatic cells derived from human pluripotent stem cells
11/17/2011	US20110280914 Hydrogels crosslinked with gold nanoparticles and methods of making and using thereof
11/17/2011	US20110280913 Methods and Compositions for Delivering Therapeutic Agents in the Treatment of B-Cell Related Disorders
11/17/2011	US20110280912 Degradable polymer nanostructure materials
11/17/2011	US20110280812 Flavor-enhancing amide compounds
11/17/2011	US20110280799 Nanocells for diagnosis and treatment of diseases and disorders
11/17/2011	US20110280798 Cell Penetrating Peptides for Intracellular Delivery
11/17/2011	US20110278763 Polyethylene oxide-based films and drug delivery systems made therefrom
11/17/2011	US20110277339 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
11/17/2011	DE102010023850A1 New nanoparticles comprising a core, a protective shell that covers the core, and heme- and hemin molecules covalently bonded to the protective shell or the core, useful as dietary supplement and for treating iron deficiency and cancer
11/17/2011	DE102010022174A1 Neue Darreichungsformen für Cineol New forms of cineole
11/17/2011	DE102010020350A1 Verfahren zur Positionierung des Fokus eines Gradientenfeldes und Behandlungsvorrichtung A process for the positioning of the focus of a gradient field and treatment device

1 ... 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 ... 2991